Moleculin Biotech, Inc.
Hedge Funds Holdings
Last updated:
Moleculin Biotech, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 5.54% of the total amount of its stocks outstanding. This makes up a total of 1.48M shares of Moleculin Biotech, Inc.. Compared to the previous quarter, the number fell by -50.27% or -1.50M shares fewer. As for the holding position changes, 35.71% (5) of current hedge fund investors increased the number of shares held, 14.29% (2) of current holders sold a part of the shares held, and 28.57% (4) closed the holdings completely. 1 hedge funds are new holders of Moleculin Biotech, Inc. stock in Q1 2023, it is 7.14% of total holders.
Hedge funds holding Moleculin Biotech (Q2 2018 – Q1 2023)
| Q2 2018 | 19 |
|---|---|
| Q3 2018 | 21 |
| Q4 2018 | 23 |
| Q1 2019 | 23 |
| Q2 2019 | 23 |
| Q3 2019 | 31 |
| Q4 2019 | 26 |
| Q1 2020 | 20 |
| Q2 2020 | 28 |
| Q3 2020 | 22 |
| Q4 2020 | 25 |
| Q1 2021 | 29 |
| Q2 2021 | 30 |
| Q3 2021 | 23 |
| Q4 2021 | 24 |
| Q1 2022 | 21 |
| Q2 2022 | 22 |
| Q3 2022 | 21 |
| Q4 2022 | 24 |
| Q1 2023 | 14 |
Hedge funds changes in Moleculin Biotech positions (Q2 2018 – Q1 2023)
| Q2 2018 | 4 | 7 | 0 | 3 | 5 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 3 | 3 | 2 | 9 |
| Q4 2018 | 5 | 7 | 4 | 3 | 4 |
| Q1 2019 | 5 | 6 | 2 | 5 | 5 |
| Q2 2019 | 4 | 5 | 1 | 4 | 9 |
| Q3 2019 | 10 | 7 | 2 | 2 | 10 |
| Q4 2019 | 4 | 3 | 4 | 9 | 6 |
| Q1 2020 | 3 | 7 | 1 | 9 | 0 |
| Q2 2020 | 14 | 4 | 2 | 6 | 2 |
| Q3 2020 | 2 | 9 | 2 | 8 | 1 |
| Q4 2020 | 7 | 2 | 6 | 3 | 7 |
| Q1 2021 | 27 | 1 | 0 | 23 | -22 |
| Q2 2021 | 7 | 6 | 2 | 6 | 9 |
| Q3 2021 | 2 | 5 | 6 | 8 | 2 |
| Q4 2021 | 7 | 3 | 3 | 7 | 4 |
| Q1 2022 | 3 | 6 | 2 | 6 | 4 |
| Q2 2022 | 4 | 4 | 7 | 3 | 4 |
| Q3 2022 | 4 | 3 | 3 | 4 | 7 |
| Q4 2022 | 7 | 5 | 5 | 3 | 4 |
| Q1 2023 | 1 | 5 | 2 | 4 | 2 |